Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
1.455
+0.005 (0.34%)
Feb 24, 2026, 4:00 PM EST - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $2.58 million as of February 25, 2026. Its market cap has decreased by -78.90% in one year.
Market Cap
2.58M
Enterprise Value
11.91M
1-Year Change
-78.90%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $2.58M, a decrease of -98.88%. That is a compound annual growth rate of -53.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 2.58M | -52.76% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 3.09M |
| Propanc Biopharma | 3.04M |
| Oragenics | 2.94M |
| Psyence Biomedical | 2.87M |
| Adial Pharmaceuticals | 2.72M |
| Artelo Biosciences | 2.66M |
| SciSparc | 2.66M |
| XORTX Therapeutics | 2.59M |